Dr. David Johnson discusses the American Cancer Society’s cancer statistics for 2024, highlighting some concerning trends, especially in gastrointestinal cancers.…
Browsing: Clinical Updates
Two retrospective analyses have revealed that the introduction of biosimilars has reduced the costs of the originator biologic, infliximab, but…
A study using data from the National Health and Nutrition Examination Survey III revealed significant gender disparities in the risk…
Takeda Pharmaceutical Company announced that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first…
The study focuses on the use of Eosinophil-Derived Neurotoxin (EDN) as a biomarker for diagnosing eosinophilic esophagitis (EoE). Dr. Yamen…
In a 24-week phase 3 randomized placebo-controlled study, oral intragastric expandable capsules have shown promising results in reducing body weight…
This software could expedite the quality review process and establish new benchmarks in colonoscopy performance. Key Features of the Software:…
This update is significant for gastroenterologists and other healthcare professionals involved in the treatment of GI tract lesions, providing them…
The study, led by Hideaki Bando from National Cancer Center Hospital East, Chiba, Japan, was presented at the ASCO Gastrointestinal…
Dr. Dana Lukin, MD, AGAF, from Weill Cornell Medical College, praised the method for its potential in confirming IBD diagnoses…